Cocrystal pharma to highlights progress with its antiviral portfolio at the virtual investor summit on march 29, 2023

Bothell, wash., march 22, 2023 (globe newswire) -- cocrystal pharma, inc. (nasdaq: cocp) announces that james martin, cfo and co-ceo, will present a company overview at the virtual investor summit conference being held on wednesday, march 29, 2023 at 10:30 a.m. eastern time.
COCP Ratings Summary
COCP Quant Ranking